Finlay Institute
 | This article relies on a single source. (July 2021) |
 | |
| Established | 1991 |
|---|---|
| Staff | 970 (2014)[1] |
| Address | Avenida 21 No. 19810 |
| Location | , Cuba |
| Coordinates | 23°04′23″N 82°27′27″W / 23.0731°N 82.4576°W |
 Interactive map of Finlay Institute | |
| Website | www |
The Finlay Institute (Spanish: Instituto Finlay de Vacunas, lit. 'Finlay Vaccine Institute') is a Cuban organization that carries out medical research and mainly produces vaccines. It is named after the Cuban doctor Carlos Finlay, who was the first to hypothesize the involvement of a mosquito as a vector of yellow fever.[2]
In response to fight against COVID-19, Finlay Institute has developed the Soberana 02.[3] In March 2021, Vicente Vérez, director of the Finlay Institute, announced a delay in the development of vaccines and indicated the start of vaccination of the Cuban population in July 2021.[4]
References
[edit]- ↑ Cuba's Maternal-Child Health - Scholar Works at UT Tyler
- ↑ Chaves-Carballo, Enrique (October 2005). "Carlos Finlay and Yellow Fever: Triumph over Adversity". Military Medicine. 170 (10): 881–885. doi:10.7205/MILMED.170.10.881. PMID 16435764.
- ↑ Reardon, Sara (22 November 2021). "Cuba's bet on home-grown COVID vaccines is paying off". Nature. 600 (7887): 15–16. Bibcode:2021Natur.600...15R. doi:10.1038/d41586-021-03470-x. PMID 34811530. S2CID 244491102.
- ↑ Cuba pospone el inicio de la vacunación con Soberana 14ymedio, 8 mars 2021
 | This article about vaccines or vaccination is a stub. You can help Wikipedia by adding missing information. |
 | This Cuba-related article is a stub. You can help Wikipedia by adding missing information. |